The relationship between stage 1 and 2 non-small cell lung cancer and lung function in men and women

被引:12
|
作者
Malhotra S. [1 ]
Lam S. [1 ,3 ]
Paul Man S.F. [1 ,2 ]
Gan W.Q. [1 ,2 ]
Sin D.D. [1 ,2 ]
机构
[1] Department of Medicine, Respiratory Division, University of British Columbia, Vancouver, BC
[2] The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, St. Paul's Hospital, Vancouver, BC
[3] British Columbia Cancer Agency, Vancouver, BC
关键词
Lung Cancer; Adenocarcinoma; Squamous Cell Carcinoma; Histological Subtype; Small Cell Carcinoma;
D O I
10.1186/1471-2466-6-2
中图分类号
学科分类号
摘要
Background: Reduced forced expiratory volume in one second (FEV1) has been linked to non small cell lung cancer (NSCLC). However, it is unclear whether all or only certain histological subtypes of NSCLC are associated with reduced FEV1. Moreover, there is little information on whether gender modifies this relationship. Using a large tissue registry, we sought to determine the relationship between FEV1 and subtypes of NSCLC and determine whether this relationship is modified by gender. Methods: We used data from patients who underwent tumor resection for NSCLC at a teaching hospital in Vancouver and had various pre-operative clinical measurements including FEV1. We divided the cohort into quartiles of predicted FEV1 and using both logistic and linear regression modeling techniques determined whether FEV1 was related to the occurrence of adeno or squamous cell carcinoma in men and women. Results: There were 610 patients in the study (36% females). On average, women were more likely to have adenocarcinoma than were men (72% of all cases of NSCLC in women versus 40% in men; p < 0.001). In women, there was no significant relationship between FEV1 and the risk of any histological subtypes of NSCLC. In men, however, there was an inverse relationship between the risk of adenocarcinoma and FEV1 such that the lowest quartile of FEV1 was 47% less likely to have adenocarcinoma compared with the highest FEV1 quartile (adjusted odds ratio, 0.52; 0.28 to 0.98; p for trend, 0.028). The reverse was observed for squamous cell carcinoma. Conclusion: In individuals undergoing lung resection for NSCLC, the risk of adenocarcinoma and squamous cell carcinoma of the lung varies as a function of FEV1, independent of smoking intensity in men but not in women. Clinical Implications: These data indicate that women are much more susceptible to adenocarcinoma than are men especially when they have normal or near normal lung function. It may thus be useful to conduct periodic surveillance chest radiographs in asymptomatic female smokers (or ex-smokers) to ascertain peripheral nodules or masses before distant metastases occur since adenocarcinomas tend to metastasize earlier in the disease course than squamous cell carcinomas. © 2006 Malhotra et al; licensee BioMed Central Ltd.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Relationship between NOB1 expression and prognosis of resected non-small cell lung cancer
    Liu, Kun
    Chen, Hong-Lin
    Gu, Ming-Ming
    You, Qing-Sheng
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2015, 30 (01): : E43 - E48
  • [42] Therapy for stage IIIB and stage IV non-small cell lung cancer
    Kim, TE
    Murren, JR
    CLINICS IN CHEST MEDICINE, 2002, 23 (01) : 209 - +
  • [43] Therapy for stage I and stage II non-small cell lung cancer
    Tanoue, LT
    Ponn, RB
    CLINICS IN CHEST MEDICINE, 2002, 23 (01) : 173 - +
  • [44] Relationship between dna damage and inflammation in primary non-small cell lung cancer
    Yardim-Akaydin, S.
    Can, E. Caliskan
    Firat, H.
    Torun, M.
    Simsek, B.
    FREE RADICAL RESEARCH, 2009, 43 : 96 - 96
  • [45] On the relationship between tumour growth rate and survival in non-small cell lung cancer
    Mistry, Hitesh B.
    PEERJ, 2017, 5
  • [46] Relationship between prognosis and nodal micrometastasis in patients with non-small cell lung cancer
    Kawaguchi, Koji
    Yatabe, Yasushi
    Yokoi, Kohei
    Mitsudomi, Tetsuya
    CHEST, 2006, 130 (04) : 232S - 232S
  • [47] Chronic Obstructive Lung Diseases and Risk of Non-small Cell Lung Cancer in Women
    Schwartz, Ann G.
    Cote, Michele L.
    Wenzaff, Angela S.
    Van Dyke, Alison
    Chen, Wei
    Ruckdeschel, John C.
    Gadgeel, Shirish
    Soubani, Ayman O.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (03) : 291 - 299
  • [48] Outcomes of sublobar and lobar resection for stage 1 non-small cell lung cancer
    Ahmed, Syeda-Saba
    Abid, Qamar
    Satur, Christopher
    Ghosh, Shilajit
    Hussain, Imran
    Bikmalla, Shiva
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [49] DO WE NEED CHEMOTHERAPY IN STAGE 1 NON-SMALL CELL LUNG CANCER?
    Thatcher, N.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S25 - S25
  • [50] Diagnosis and treatment of lung cancer - Non-small cell lung cancer, small cell lung cancer and carcinoids
    End A.
    European Surgery, 2006, 38 (1) : 45 - 53